Literature DB >> 15187131

Transcriptional regulation of human CD5: important role of Ets transcription factors in CD5 expression in T cells.

Mònica Arman1, Javier Calvo, Maria E Trojanowska, Peter N Cockerill, Mónica Santana, Manuel López-Cabrera, Jordi Vives, Francisco Lozano.   

Abstract

CD5 is a surface receptor constitutively expressed on thymocytes and mature T and B-1a cells. CD5 expression is tightly regulated during T and B cell development and activation processes. In this study we shown that the constitutive expression of CD5 on human T cells correlates with the presence of a DNase I-hypersensitive (DH) site at the 5'-flanking region of CD5. Human CD5 is a TATA-less gene for which 5'-RACE analysis shows multiple transcriptional start sites, the most frequent of which locates within an initiator sequence. Luciferase reporter assays indicate that a 282-bp region upstream of the initiation ATG displays full promoter activity in human T cells. Two conserved Ets-binding sites (at positions -239 and -185) were identified as functionally relevant to CD5 expression by site-directed mutagenesis, EMSAs, and cotransfection experiments. A possible contribution of Sp1 (-115 and -95), c-Myb (-177), and AP-1-like (-151) motifs was also detected. Further DH site analyses revealed an inducible DH site 10 kb upstream of the human CD5 gene in both T and B CD5(+) cells. Interestingly, a 140-bp sequence showing high homology with a murine inducible enhancer is found within that site. The data presented indicate that the 5'-flanking region of human CD5 is transcriptionally active in T cells, and that Ets transcription factors in conjunction with other regulatory elements are responsible for constitutive and tissue-specific CD5 expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187131     DOI: 10.4049/jimmunol.172.12.7519

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  A conserved enhancer element differentially regulates developmental expression of CD5 in B and T cells.

Authors:  Robert Berland; Steven Fiering; Henry H Wortis
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

2.  Differential transcription factor use by the KIR2DL4 promoter under constitutive and IL-2/15-treated conditions.

Authors:  Steven R Presnell; Lei Zhang; Corrin N Chlebowy; Ahmad Al-Attar; Charles T Lutz
Journal:  J Immunol       Date:  2012-03-30       Impact factor: 5.422

3.  Transcriptional regulation of mouse L-selectin.

Authors:  Xitong Dang; Nikolai A Raffler; Klaus Ley
Journal:  Biochim Biophys Acta       Date:  2008-11-11

4.  Regulation of natriuretic peptide receptor-A gene expression and stimulation of its guanylate cyclase activity by transcription factor Ets-1.

Authors:  Prerna Kumar; Gevoni Bolden; Kiran K Arise; Stephen T Krazit; Kailash N Pandey
Journal:  Biosci Rep       Date:  2009-02       Impact factor: 3.840

5.  Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases.

Authors:  Ruby Alonso-Ramirez; Séverine Loisel; Caroline Buors; Jacques-Olivier Pers; Enrique Montero; Pierre Youinou; Yves Renaudineau
Journal:  Arthritis       Date:  2011-02-10

6.  Greater frequency of CD5-negative CD8(+) T cells against human immunodeficiency virus type 1 than other viruses is consistent with adaptation to antigenic variation.

Authors:  Stephen J Penney; Maureen E Gallant; Michael D Grant
Journal:  AIDS Res Ther       Date:  2014-09-15       Impact factor: 2.250

7.  Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies.

Authors:  Songnan Sui; Zhiyan Li; Jiaxiong Tan; Liang Wang; Gengxin Luo; Chengwu Zeng; Oscar Junhong Luo; Cunte Chen; Yangqiu Li
Journal:  J Oncol       Date:  2022-08-09       Impact factor: 4.501

8.  The transcription factor Ets1 is important for CD4 repression and Runx3 up-regulation during CD8 T cell differentiation in the thymus.

Authors:  Monica Zamisch; Linhua Tian; Roland Grenningloh; Yumei Xiong; Kathryn F Wildt; Marc Ehlers; I-Cheng Ho; Rémy Bosselut
Journal:  J Exp Med       Date:  2009-11-16       Impact factor: 14.307

9.  CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer.

Authors:  Andrea Moreno-Manuel; Eloisa Jantus-Lewintre; Ines Simões; Fernando Aranda; Silvia Calabuig-Fariñas; Esther Carreras; Sheila Zúñiga; Yvonne Saenger; Rafael Rosell; Carlos Camps; Francisco Lozano; Rafael Sirera
Journal:  Transl Lung Cancer Res       Date:  2020-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.